Press Release

AI-powered analysis of Phase 3 CHARM trial suggests that Brainomix non-contrast CT (NCCT) technology may help identify severe stroke patients more likely to benefit from CIRARA, supporting more precise patient selection and the design of future stroke trials.

Results from operations for third quarter 2026 versus third quarter 2025:

The launch of the Liverty™ TIPS Stent Graft gives physicians flexibility to tailor treatment for patients.

Operating Profit [ 1] Increases 8.3% YoY and Equity Rises 4.4% YTD

MARLBOROUGH, Mass. , Oct. 28, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.138 billion during the third quarter of 2026, growing 1.5 percent on a reported, operational 1 and organic 2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $582 million or $0.40 per share (EPS), compared to $755 million or $0.51 per share a year ago, and achieved adjusted 3 EPS of $0.73 for the period, compared to $0.75 a year ago.

Net sales of $1,698.3 million; increase of 4.6%; organic increase of 5.2%

O-Cyte 1 combines CBC testing and reviewable cell images with expandable throughput and service-ready design.

O-Cyte 1 combines CBC testing and reviewable cell images with expandable throughput and service-ready design.

OSLO, Norway , Oct. 28, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix® /Cysview® revenues of NOK 134.2 million in the third quarter of 2026 (Q3 2025: NOK 134.1 million), and Adjusted EBITDA of NOK 18.5 million (Q3 2025: NOK 18.9 million). In 2026, Photocure now expects product revenue growth in the range of 10% to 12% on a constant currency basis (versus 8 to 11% previously) and adjusted EBITDA margin expansion.

SEOUL, South Korea , Oct. 28, 2026 /PRNewswire/ -- Bright Eye Clinic has been honored with the "Ophthalmology Wellness Clinic of the Year in Korea" award at the 2026 GlobalHealth Asia-Pacific Awards , recognizing its sustained excellence in patient care and commitment to long-term eye health outcomes. This distinction highlights the clinic's unique position as a premier destination for international patients seeking advanced vision correction and cataract care in South Korea.

Saudi Arabia launch opens the region, with expansion planned into Egypt, Turkey, Jordan and Iraq; Ask Dx is the core platform

SEOUL, South Korea , Oct. 28, 2026 /PRNewswire/ -- People&Technology (PnT), a smart hospital solution provider, is validating its smart hospital technologies at Prince Sultan Military Medical City (PSMMC), one of Saudi Arabia's largest medical cities, operating under the Kingdom's Ministry of Defense.

GUANGZHOU, China , Oct. 28, 2026 /PRNewswire/ -- Fosun Health has become the first cross-border international healthcare group to exhibit at the Canton Fair in its 70-year history, debuting at the event's inaugural International Healthcare Zone alongside four Greater Bay Area (GBA) hospitals, including Foshan Fosun Chancheng Hospital .

Partnerships expand surgical microscope service and sales across 18 states

BREA, Calif. , Oct. 27, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced the publication of its 2025 Sustainability Report. The report provides an update on Envista's progress in expanding access to dental care, supporting employees and communities, improving environmental efficiency, and maintaining strong ethical and governance practices. The full report can be found on Envista's website.

The article outlines how each type of pregnancy ultrasound supports fetal development and family understanding.

GRAND RAPIDS, Mich. , Oct. 27, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will participate in the following upcoming investor conferences:

SUNNYVALE, Calif. , Oct. 27, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the UBS Global Healthcare Conference in Palm Beach, FL on Tuesday, Nov. 10 at 11:00 a.m. ET.

New state-of-the-art facility in North Carolina will strengthen supply chain resilience, expand manufacturing capacity and reinforce Bracco's long-term commitment to the U.S. market

Statement outlines a structured approach to recognizing, evaluating, and managing right heart failure across the spectrum of cardiovascular disease